Search

Your search keyword '"ADC Therapeutics S.A. -- Forecasts and trends"' showing total 7 results
Start Over Descriptor "ADC Therapeutics S.A. -- Forecasts and trends" Journal plus company updates
7 results on '"ADC Therapeutics S.A. -- Forecasts and trends"'

1. Antibody-Drug Conjugates Market to Grow at 28.4% CAGR from 2024 to 2029

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Reports -- Forecasts and trends, Viral antibodies -- Reports -- Forecasts and trends, Antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

BOSTON: BCC Research LLC has issued the following press release: 'According to the latest BCC Research study, 'The global ADCs market is showing a rapid growth trend, with growth rates [...]

Published
2024

2. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according [...]

Published
2024

3. Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Statistics, Independent regulatory commissions -- Forecasts and trends -- Statistics, Antineoplastic agents -- Statistics, Monoclonal antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Antimitotic agents -- Statistics, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: MarketsandMarkets has issued the following news release: The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals. ADCs are a class [...]

Published
2023

4. Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Genentech Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Beam Therapeutics Inc. -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends, Biological products industry -- Forecasts and trends, Business -- Research, Patient compliance -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Antigens -- Forecasts and trends, Acute lymphocytic leukemia -- Forecasts and trends, Cancer -- Research, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release:= DelveInsight's Acute Lymphocytic Leukemia Market Insights report includes a comprehensive understanding of current treatment practices, acute lymphocytic leukemia [...]

Published
2023

5. Global Antibody Drug Conjugates (ADC) Markets, 2022-2028: Increasing Cases of Cancer with ADCs Showing to be a Substitute for Conventional Cancer Treatments Like Chemotherapy or Combination Therapy (Updated on September 15, 2022)

Subjects
United States. Food and Drug Administration -- Statistics, ADC Therapeutics S.A. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Forecasts and trends, Chemotherapy -- Forecasts and trends -- Statistics, Cancer -- Chemotherapy, Antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional Outlook [...]

Published
2022

6. Worldwide Antibody Drug Conjugates Industry to Register CAGR of 12.8% during 2021 - 2026

Subjects
Catalent Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, ImmunoGen Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Biopharmaceutics -- Forecasts and trends, Viral antibodies -- Forecasts and trends, Antibodies -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: The report 'Antibody Drug Conjugates Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)' is now offered by ResearchAndMarkets.com. In the report, the antibody-drug conjugates market is [...]

Published
2022

7. Relapsed or Refractory Diffuse Large B-cell Lymphoma Markets, 2028

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Relapsed or Refractory Diffuse Large B-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results